Effects of the application of erythropoietin on cerebral recovery after cardiac arrest in rats
- PMID: 17382452
- DOI: 10.1016/j.resuscitation.2007.01.019
Effects of the application of erythropoietin on cerebral recovery after cardiac arrest in rats
Abstract
Background: After transient global cerebral ischaemia, selectively vulnerable areas of the brain show delayed neuronal degeneration. Recent data have demonstrated potent neuroprotective effects of the application of growth hormones like erythropoietin (EPO) after focal cerebral ischaemia. In order to assess possible effects of the application of EPO on cerebral recovery after cardiac arrest in rats, the vulnerable hippocampal CA-1 sector was investigated.
Methods: Thirty male Wistar rats were randomised into two groups (EPO versus placebo; n=15 per group). Cardiac arrest was induced by ventricular fibrillation during general anaesthesia. After 6 min of global cerebral ischaemia, animals were resuscitated by external chest compressions combined with defibrillation. Investigator blinded bolus application of EPO (5000 IE/kg bodyweight) and placebo was performed at three different time points, respectively: 5 min before cardiac arrest (i.v.; intravenously), 24h (i.p.; intraperitoneally) and 72 h (i.p.) after ischaemia. At 24h, 72 h and 7 days, animals were tested according to a neurological deficit score. After of reperfusion, coronal brain sections were analysed by TUNEL- and Nissl-staining. A caspase activity assay was done to determine antiapoptotic properties of EPO. Statistical analyses were done using ANOVA.
Results: Neurological deficit scoring did not show differences between the groups. However, in all groups typical delayed neuronal degeneration could be found in the CA-1 sector. There was no difference in neuronal survival between the groups (viable neurons EPO (median [interquartile range]): 15.5 [10.1-21.3]; placebo: 16.8 [7.7-26.3]). Results from TUNEL-staining revealed no differences in the amount of apoptotic cell death between the groups (EPO: 71.2 [58.1-81.8]; placebo: 73.4 [67.8-78.2]). Caspase activity assays demonstrated a strong expression of general caspase activity as well as caspase-3 activity in the CA-1 sector and the nucleus reticularis thalami, without any differences between both groups.
Conclusion: Despite the well known neuroprotective properties of EPO in ischaemia induced neuronal degeneration, this study could not reveal any beneficial effects of EPO after global cerebral ischaemia due to cardiac arrest in rats.
Comment in
-
Effects of erythropoietin on neurological recovery after cardiac arrest.Resuscitation. 2008 Feb;76(2):315-6; author reply 316-7. doi: 10.1016/j.resuscitation.2007.06.034. Epub 2007 Oct 23. Resuscitation. 2008. PMID: 17936494 No abstract available.
Similar articles
-
The effect of intracerebroventricular application of the caspase-3 inhibitor zDEVD-FMK on neurological outcome and neuronal cell death after global cerebral ischaemia due to cardiac arrest in rats.Resuscitation. 2008 Jul;78(1):85-91. doi: 10.1016/j.resuscitation.2008.02.010. Epub 2008 May 2. Resuscitation. 2008. PMID: 18455860
-
Hypothermia and neuroprotection by sulfide after cardiac arrest and cardiopulmonary resuscitation.Resuscitation. 2011 Aug;82(8):1076-80. doi: 10.1016/j.resuscitation.2011.03.038. Epub 2011 Apr 20. Resuscitation. 2011. PMID: 21550709
-
Vasopressors are essential during cardiopulmonary resuscitation in rats: Is vasopressin superior to adrenaline?Resuscitation. 2007 Jan;72(1):137-44. doi: 10.1016/j.resuscitation.2006.05.015. Epub 2006 Oct 27. Resuscitation. 2007. PMID: 17069949
-
[Erythropoietin--a new therapy in cerebral ischemia?].Ugeskr Laeger. 2003 Jun 9;165(24):2477-81. Ugeskr Laeger. 2003. PMID: 12872467 Review. Danish.
-
Studies of isolated global brain ischaemia: I. Overview of irreversible brain injury and evolution of a new concept - redefining the time of brain death.Eur J Cardiothorac Surg. 2012 May;41(5):1132-7. doi: 10.1093/ejcts/ezr315. Epub 2012 Mar 6. Eur J Cardiothorac Surg. 2012. PMID: 22398465 Review.
Cited by
-
Protecting mitochondrial bioenergetic function during resuscitation from cardiac arrest.Crit Care Clin. 2012 Apr;28(2):245-70. doi: 10.1016/j.ccc.2012.02.001. Crit Care Clin. 2012. PMID: 22433486 Free PMC article. Review.
-
Erythropoietin: powerful protection of ischemic and post-ischemic brain.Exp Biol Med (Maywood). 2014 Nov;239(11):1461-75. doi: 10.1177/1535370214523703. Epub 2014 Mar 4. Exp Biol Med (Maywood). 2014. PMID: 24595981 Free PMC article. Review.
-
Post-ischemic continuous infusion of erythropoeitin enhances recovery of lost memory function after global cerebral ischemia in the rat.BMC Neurosci. 2013 Mar 12;14:27. doi: 10.1186/1471-2202-14-27. BMC Neurosci. 2013. PMID: 23497299 Free PMC article. Clinical Trial.
-
Bone marrow mesenchymal stem cells repair the hippocampal neurons and increase the expression of IGF-1 after cardiac arrest in rats.Exp Ther Med. 2017 Nov;14(5):4312-4320. doi: 10.3892/etm.2017.5059. Epub 2017 Aug 28. Exp Ther Med. 2017. PMID: 29067112 Free PMC article.
-
The role of erythropoietin in remote renal preconditioning on hippocampus ischemia/reperfusion injury.J Physiol Sci. 2017 Jan;67(1):163-171. doi: 10.1007/s12576-016-0451-6. Epub 2016 Apr 20. J Physiol Sci. 2017. PMID: 27099131 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous